These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10079144)

  • 1. Relationship between autofluorescence and advanced glycation end products in diabetic lenses.
    Abiko T; Abiko A; Ishiko S; Takeda M; Horiuchi S; Yoshida A
    Exp Eye Res; 1999 Mar; 68(3):361-6. PubMed ID: 10079144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the crystalline lens by fluorophotometry in 60 control subjects and 56 diabetics].
    Bordat B; Laudeho A; Guirguis IR; Arnaud C
    J Fr Ophtalmol; 1992; 15(2):113-8. PubMed ID: 1640064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lens transmission of blue-green light in diabetic patients as measured by autofluorophotometry.
    van Best JA; Vrij L; Oosterhuis JA
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):532-6. PubMed ID: 3980169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fluorescent products in the crystalline lens of type ii diabetic patients].
    Silva J; Freitas JP; Filipe P; Vendrell E; Rodrigo FG
    Acta Med Port; 1996; 9(7-9):237-9. PubMed ID: 9005703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications.
    Gerrits EG; Lutgers HL; Kleefstra N; Graaff R; Groenier KH; Smit AJ; Gans RO; Bilo HJ
    Diabetes Care; 2008 Mar; 31(3):517-21. PubMed ID: 18039805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autofluorescence characterization of advanced glycation end products of hemoglobin.
    Vigneshwaran N; Bijukumar G; Karmakar N; Anand S; Misra A
    Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(1-2):163-70. PubMed ID: 15556435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autofluorescence of the lens in diabetic and healthy subjects by fluorophotometry.
    Bleeker JC; van Best JA; Vrij L; van der Velde EA; Oosterhuis JA
    Invest Ophthalmol Vis Sci; 1986 May; 27(5):791-4. PubMed ID: 3700028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autofluorescence distribution along the corneal axis in diabetic and healthy humans.
    Van Schaik HJ; Coppens J; Van den Berg TJ; Van Best JA
    Exp Eye Res; 1999 Nov; 69(5):505-10. PubMed ID: 10548470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autofluorescence of the diabetic and healthy human cornea in vivo at different excitation wavelengths.
    Van Schaik HJ; Alkemade C; Swart W; Van Best JA
    Exp Eye Res; 1999 Jan; 68(1):1-8. PubMed ID: 9986736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical detection of glycated beta- and gamma-crystallins in lens and their circulating autoantibodies (IgG) in streptozocin induced diabetic rat.
    Ranjan M; Nayak S; Rao BS
    Mol Vis; 2006 Sep; 12():1077-85. PubMed ID: 17093392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo.
    Obayashi H; Nakano K; Shigeta H; Yamaguchi M; Yoshimori K; Fukui M; Fujii M; Kitagawa Y; Nakamura N; Nakamura K; Nakazawa Y; Ienaga K; Ohta M; Nishimura M; Fukui I; Kondo M
    Biochem Biophys Res Commun; 1996 Sep; 226(1):37-41. PubMed ID: 8806589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of lens autofluorescence by fluorophotometry in pregnancy.
    Beneyto P; Pérez TM
    Exp Eye Res; 2006 Apr; 82(4):583-7. PubMed ID: 16256986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical evidence for increased formation of advanced glycation end products and inhibition by aminoguanidine in diabetic rat lenses.
    Matsumoto K; Ikeda K; Horiuchi S; Zhao H; Abraham EC
    Biochem Biophys Res Commun; 1997 Dec; 241(2):352-4. PubMed ID: 9425275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes.
    Lutgers HL; Graaff R; Links TP; Ubink-Veltmaat LJ; Bilo HJ; Gans RO; Smit AJ
    Diabetes Care; 2006 Dec; 29(12):2654-9. PubMed ID: 17130200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
    Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
    Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation endproducts in human diabetic and non-diabetic cataractous lenses.
    Pokupec R; Kalauz M; Turk N; Turk Z
    Graefes Arch Clin Exp Ophthalmol; 2003 May; 241(5):378-84. PubMed ID: 12698254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal autofluorescence: an indicator of diabetic retinopathy.
    Stolwijk TR; van Best JA; Oosterhuis JA; Swart W
    Invest Ophthalmol Vis Sci; 1992 Jan; 33(1):92-7. PubMed ID: 1730550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis.
    Gerdemann A; Lemke HD; Nothdurft A; Heidland A; Münch G; Bahner U; Schinzel R
    Clin Nephrol; 2000 Oct; 54(4):276-83. PubMed ID: 11076103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentosidine and autofluorescence in lenses of diabetic patients.
    Hashimoto H; Arai K; Yoshida S; Chikuda M; Obara Y
    Jpn J Ophthalmol; 1997; 41(5):274-7. PubMed ID: 9363554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Color matching in diabetes: optical density of the crystalline lens and macular pigments.
    Davies NP; Morland AB
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):281-9. PubMed ID: 11773043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.